4:00 pm to 5:00 pm (reception following at Sandler Neuroscience Building)
UCSF Mission Bay Campus
Byers Auditorium, Genentech Hall
600 16th Street, San Francisco (entrance from Koret Quad)
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) is the single largest and most detailed scientific effort ever conducted to quantify levals and trends in health. Led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, it is truly a global effort, with over 1,000 researchers from more than 100 countries, including 26 low- and middle-income countries, participating in the most recent update
Dr. Harvey Whiteford will make the first public presentation of the GBD 2016 data, also to be featured in The Lancet beginning with the mid-September issue. Dr. Whiteford is one of the foremost leaders in the field of global mental health/neurological health. He and his team in Queensland are largely responsible for illiuminating the global burden of mental/neurological disorders through their repeated epidemiological analyses and high-level publications of the GBD data.
Dr. Harvey Whiteford
Dr. Harvey Whiteford is Professor of Psychiatry and Population Mental Health at the University of Queensland, Australia and Professor of Global Health at the Institute of Health Metrics and Evaluation, University of Washington, Seattle. He trained in medicine, psychiatry and public health at the University of Queensland, the australian National University and Stanford University. He has held senior clinical and administrative positions including Director of Mental Health in the Austrialian Federal government and at the World Bank where he was the advisor for the neuropsychiatric program. His expertise is in psychiatric epidemiology, burden of disease modeling and mental health service development, and he has worked in these areas with the World Health Organization, OECD and governments in Europe, Africa and Asia.
Presented by Atlantic Fellows for Equity in Brain Health